Alex Delaney-Gesing, Senior Editor

Maria Sampalis, OD, shares what she wishes she knew before entering the field.

Ahead of this year's annual meeting, Mohammad Rafieetary, OD, FAAO, offers a look at his presentation on diabetic retinal diseases and shares why the event shouldn't be missed.

AREDS2 formula doesn’t contain beta carotene, reducing the risk of lung cancer.

John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA, shares highlights from his Vision Expo West presentation: "Corneal diagnostics: A-Z."

Alexis Malkin, OD, FAAO, highlights her Vision Expo West 2022 presentation titled, "Expand your practice: how to integrate low vision into everyday patient care and improve outcomes."

John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA, discusses his presentation titled"Keratoconus 1, 2, 3: simple management," during Vision Expo West.

Jacob R. Lang, OD, FAAO, highlights his Vision Expo West presentation,"An update on systemic conditions and medications you must look out for in OSD management."

At Vision Expo West 2022, Valerie M. Kattouf, OD, shares her best practices for managing prescription formulas for pediatric patients.

Valerie M. Kattouf, OD, discusses going back to the basics of neuro-ophthalmology + managing vision and visual-motor abnormalities in patients.

Valerie M. Kattouf, OD, shares key highlights and takeaways from her 2022 Vision Expo West presentation titled "Myopia Control."

With the launch of dark adaptation, Heru is now the only platform on the AMD market to include contrast sensitivity and dark adaptation exams.

Azura has secured funding to support its 2-stage study evaluating the safety, tolerability, and efficacy of AZR-MD-001, its leading candidate, for patients with contact lens discomfort who show signs of meibomian gland dysfunction.

OCS-01 is a novel, high concentration, preservative free, topical formulation of dexamethasone that has the potential to be the first topical eye drop and non-invasive treatment for DME.

Bausch + Lomb and Novaliqu announced that the FDA has accepted its New Drug Application for NOV03, an investigational treatment for dry eye disease associated with meibomian gland dysfunction.

Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.

Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on advanced fitting and troubleshooting tips for scleral lenses during the South Carolina Optometric Physicians Association’s annual meeting.

Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on amniotic membrane treatment for anterior segment disease during the South Carolina Optometric Physicians Association’s annual meeting.

Leo P. Semes, OD, FAAO, highlights his presentation on "Artificial intelligence and telemedicine," presented during the 115th annual SCOPA meeting.

Leo P. Semes, OD, FAAO, discusses his presentation on, "A new look at AMD," during the South Carolina Optometric Physicians Association's annual meeting.

Leo P. Semes, OD, FAAO, discusses his presentation on, "When glaucoma isn't glaucoma," during the South Carolina Optometric Physicians Association's annual meeting.

Latest data from phase 3 studies finds increased effects over time with intravitreal pegcetacoplan for geographic atrophy secondary to age-related macular degeneration.

Latest transaction, totaling approximately $770 million, adds key commercial products and clinical/preclinical product candidates in the pipeline.

EyeCare4Kids founder Joseph Carbone discusses the nonprofit organization's mission to offer services in local communities, as well as its expansion into underserved communities across the globe.

Results are in for this year's award recipients!

Published in Optometry & Visual Sciences, the findings are based on an independent survey featuring feedback from over 500 US eye care professionals.

Results from a parallel arm study suggest opportunity to expand on visual performance and productivity improvement.

COMET-3 is the second of 3 studies in the AR-15512 Registrational Phase 3 Program, which is slated for completion by 2023.

After surveying over 10,000 professionals from the nation's eyecare workforce, the results are in for this year's top 175 optometrists.

AcuFocus's IC-8 Apthera IOL features a proprietary small aperture technology that filters out peripheral defocused light and allows only focused light to reach the retina.

Adam Ramsey, OD, discusses his recent book titled, "Play Chess Not Checkers: The Practical Guide to Warm Start Your Dream Optometric Practice."